78360 Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices 

or other forms of information 

technology to minimize the information 

collection burden. 

Darius Taylor, 

Deputy, Information Collection Clearance 

Officer. 

[FR Doc. 2013–30840 Filed 12–24–13; 8:45 am] 

BILLING CODE 4150–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 10 

(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ RFA–HS14–003, 

Disseminating Patient Centered 

Outcomes Research to Improve 

Healthcare Delivery Systems (R18)’’. 

Each SEP meeting will commence in 

open session before closing to the public 

for the duration of the meeting. 

DATES: January 15–17, 2014 (Open on 

January 15 from 5:00 p.m. to 6:00 p.m. 

and closed for the remainder of the 

meeting). 

ADDRESSES: Gaithersburg Marriott 

Washingtonian Center, 9751 

Washingtonian Boulevard, Gaithersburg, 

Maryland 20878. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Each SEP meeting will commence in 

open session before closing to the public 

for the duration of the meeting. The SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

the ‘‘AHRQ RFA–HS14–003, 

Disseminating Patient Centered 

Outcomes Research to Improve 

Healthcare Delivery Systems (R18)’’ are 

to be reviewed and discussed at this 

meeting. The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Dated: December 17, 2013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–30901 Filed 12–24–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice. 

SUMMARY: In accordance with section 10 

(a)(2) of the Federal Advisory 

Committee Act (5 U.S.C. App. 2), 

announcement is made of an Agency for 

Healthcare Research and Quality 

(AHRQ) Special Emphasis Panel (SEP) 

meeting on ‘‘AHRQ RFA–HS14–004, 

PCOR AHRQ Training Program on 

Patient-Centered Outcomes Methods & 

Standard Research (R25)’’. Each SEP 

meeting will commence in open session 

before closing to the public for the 

duration of the meeting. 

DATES: January 17, 2014 (Open on 

January 17 from 8:00 a.m. to 9:00 a.m. 

and closed for the remainder of the 

meeting). 

ADDRESSES: Gaithersburg Marriott 

Washingtonian Center, 9751 

Washingtonian Boulevard, Gaithersburg, 

Maryland 20878. 

FOR FURTHER INFORMATION CONTACT: 

Anyone wishing to obtain a roster of 

members, agenda or minutes of the nonconfidential portions of this meeting 

should contact: Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research, Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Room 2038, Rockville, 

Maryland 20850, Telephone: (301) 427– 

1554. 

Agenda items for this meeting are 

subject to change as priorities dictate. 

SUPPLEMENTARY INFORMATION: A Special 

Emphasis Panel is a group of experts in 

fields related to health care research 

who are invited by the Agency for 

Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Each SEP meeting will commence in 

open session before closing to the public 

for the duration of the meeting. The SEP 

meeting referenced above will be closed 

to the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2, 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6). Grant applications for 

the ‘‘AHRQ RFA–HS14–004, PCOR 

AHRQ Training Program on PatientCentered Outcomes Methods & 

Standards Research (R25)’’ are to be 

reviewed and discussed at this meeting. 

The grant applications and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Dated: December 17, 2013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–30899 Filed 12–24–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of Five AHRQ 

Subcommittee Meetings. 

SUMMARY: The subcommittees listed 

below are part of AHRQ’s Health 


emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 248 / Thursday, December 26, 2013 / Notices 78361 

Services Research Initial Review Group 

Committee. Grant applications are to be 

reviewed and discussed at these 

meetings. Each subcommittee meeting 

will commence in open session before 

closing to the public for the duration of 

the meeting. These meetings will be 

closed to the public in accordance with 

5 U.S.C. App. 2 section 10(d), 5 U.S.C. 

section 552b(c)(4), and 5 U.S.C. section 

552b(c)(6). 

DATES: See below for dates of meetings: 

1. Health System and Value Research 

(HSVR) 

Date: February 19, 2014 (Open from 

8:00 a.m. to 8:30 a.m. on February 19 

and closed for remainder of the meeting) 

2. Healthcare Safety and Quality 

Improvement Research (HSQR) 

Date: February 26–27, 2014 (Open 

from 8:00 a.m. to 8:30 a.m. on February 

26 and closed for remainder of the 

meeting) 

3. Healthcare Effectiveness and 

Outcomes Research (HEOR) 

Date: February 26–27, 2014 (Open 

from 8:30 a.m. to 9:00 a.m. on February 

26 and closed for remainder of the 

meeting) 

4. Health Care Research and Training 

(HCRT) 

Date: February 27–28, 2014 (Open 

from 8:00 a.m. to 8:30 a.m. on February 

27 and closed for remainder of the 

meeting) 

5. Healthcare Information Technology 

Research (HITR) 

Date: February 27–28, 2014 (Open 

from 8:00 a.m. to 8:30 a.m. on February 

27 and closed for remainder of the 

meeting) 

ADDRESSES: Gaithersburg Marriott 

Washingtonian Center, 9751 

Washingtonian Boulevard, Gaithersburg, 

Maryland 20878. 

FOR FURTHER INFORMATION CONTACT: (To 

obtain a roster of members, agenda or 

minutes of the non-confidential portions 

of the meetings.) Mrs. Bonnie Campbell, 

Committee Management Officer, Office 

of Extramural Research Education and 

Priority Populations, AHRQ, 540 

Gaither Road, Suite 2000, Rockville, 

Maryland 20850, Telephone (301) 427– 

1554. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 10(a)(2) of the 

Federal Advisory Committee Act (5 

U.S.C. App. 2), AHRQ announces 

meetings of the scientific peer review 

groups listed above, which are 

subcommittees of AHRQ’s Health 

Services Research Initial Review Group 

Committees. Each subcommittee 

meeting will commence in open session 

before closing to the public for the 

duration of the meeting. The 

subcommittee meetings will be closed to 

the public in accordance with the 

provisions set forth in 5 U.S.C. App. 2 

section 10(d), 5 U.S.C. 552b(c)(4), and 5 

U.S.C. 552b(c)(6) The grant applications 

and the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Agenda items for these meetings are 

subject to change as priorities dictate. 

Dated: December 17, 2013. 

Richard Kronick, 

AHRQ Director. 

[FR Doc. 2013–30888 Filed 12–24–13; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[60-Day 14–14FA] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 or send 

comments to LeRoy Richardson, 1600 

Clifton Road, MS–D74, Atlanta, GA 

30333 or send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

State Surveillance under the National 

Toxic Substance Incidents Program 

(NTSIP)—NEW—Agency for Toxic 

Substances and Disease Registry 

(ATSDR). 

Background and Brief Description 

The Agency for Toxic Substances and 

Disease Registry (ATSDR) is sponsoring 

the National Toxic Substance Incidents 

Program (NTSIP) to gather information 

from many resources to protect people 

from harm caused by spills and leaks of 

toxic substances. The NTSIP 

information will be used to help prevent 

or reduce the harm caused by toxic 

substance incidents. The NTSIP is 

modeled partially after the Hazardous 

Substances Emergency Events 

Surveillance (HSEES) Program which 

ran from 1992 to 2012 [OMB number: 

0923–0008; expiration date 01/31/2012], 

with additions suggested by 

stakeholders to have a more complete 

program. The NTSIP has three 

components: a national database, state 

surveillance, and the response team. 

This information collection request is 

focused on the state surveillance 

component. 

The NTSIP is the only federal public 

health-based surveillance system to 

coordinate the collection, collation, 

analysis, and distribution of acute toxic 

substance incidents data to public 

health and safety practitioners. Because 

thousands of acute spills occur annually 

around the country, it is necessary to 

establish this surveillance system to 

describe the public health impacts on 

the population of the United States. The 

ATSDR is seeking a three-year approval 

for the ongoing collection of information 

for the state surveillance system. 

The main objectives of this 

information collection are to: 

1. describe toxic substance releases 

and the public health consequences 

associated with such releases within the 

participating states, 

2. identify and prioritize 

vulnerabilities in industry, 

transportation, and communities as they 

relate to toxic substance releases, and 

3. identify, develop, and promote 

strategies that could prevent ongoing 

and future exposures and resultant 

health effects from toxic substance 

releases. 

The NTSIP surveillance system will 

be incident-driven and all acute toxic 

substance incidents occurring within 

the participating states will be included. 

Upon Office of Management and Budget 

(OMB) approval, participating states 

will include Alaska, California, 

Louisiana, Michigan, Missouri, New 

York, North Carolina, Oregon, 

Tennessee, Utah, and Wisconsin. 

A standardized set of data will be 

collected by the NTSIP coordinator for 


emcdonald on DSK67QTVN1PROD with NOTICES